Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

A model-based imputation procedure for multilevel regression models with random coefficients, interaction effects, and nonlinear terms.

Enders CK, Du H, Keller BT.

Psychol Methods. 2019 Jul 1. doi: 10.1037/met0000228. [Epub ahead of print]

PMID:
31259566
2.

A Fully Conditional Specification Approach to Multilevel Multiple Imputation with Latent Cluster Means.

Keller BT, Du H.

Multivariate Behav Res. 2019 Jan-Feb;54(1):149-150. doi: 10.1080/00273171.2018.1556085. No abstract available.

PMID:
31074655
3.

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.

Tiessen RG, Kennedy CA, Keller BT, Levin N, Acevedo L, Gedulin B, van Vliet AA, Dorenbaum A, Palmer M.

BMC Gastroenterol. 2018 Jan 5;18(1):3. doi: 10.1186/s12876-017-0736-0.

4.

A fully conditional specification approach to multilevel imputation of categorical and continuous variables.

Enders CK, Keller BT, Levy R.

Psychol Methods. 2018 Jun;23(2):298-317. doi: 10.1037/met0000148. Epub 2017 May 29.

PMID:
28557466
5.

Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.

Rao A, Kosters A, Mells JE, Zhang W, Setchell KD, Amanso AM, Wynn GM, Xu T, Keller BT, Yin H, Banton S, Jones DP, Wu H, Dawson PA, Karpen SJ.

Sci Transl Med. 2016 Sep 21;8(357):357ra122. doi: 10.1126/scitranslmed.aaf4823.

6.

Multilevel multiple imputation: A review and evaluation of joint modeling and chained equations imputation.

Enders CK, Mistler SA, Keller BT.

Psychol Methods. 2016 Jun;21(2):222-40. doi: 10.1037/met0000063. Epub 2015 Dec 21. Review.

PMID:
26690775
7.

Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.

Miethke AG, Zhang W, Simmons J, Taylor AE, Shi T, Shanmukhappa SK, Karns R, White S, Jegga AG, Lages CS, Nkinin S, Keller BT, Setchell KD.

Hepatology. 2016 Feb;63(2):512-23. doi: 10.1002/hep.27973. Epub 2015 Aug 21.

8.

Analyzing person, situation and person × situation interaction effects: Latent state-trait models for the combination of random and fixed situations.

Geiser C, Litson K, Bishop J, Keller BT, Burns GL, Servera M, Shiffman S.

Psychol Methods. 2015 Jun;20(2):165-92. doi: 10.1037/met0000026. Epub 2014 Dec 22. Review.

PMID:
25528499
9.

Distinguishing state variability from trait change in longitudinal data: the role of measurement (non)invariance in latent state-trait analyses.

Geiser C, Keller BT, Lockhart G, Eid M, Cole DA, Koch T.

Behav Res Methods. 2015 Mar;47(1):172-203. doi: 10.3758/s13428-014-0457-z.

10.

A nanofiber membrane maintains the quiescent phenotype of hepatic stellate cells.

Eda H, Kulig KM, Steiner TA, Shimada H, Patel K, Park E, Kim ES, Borenstein JT, Neville CM, Keller BT.

Dig Dis Sci. 2012 May;57(5):1152-62. doi: 10.1007/s10620-012-2084-9. Epub 2012 Feb 23.

PMID:
22359192
11.

Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 2).

Huang HC, Tremont SJ, Lee LF, Keller BT, Carpenter AJ, Wang CC, Banerjee SC, Both SR, Fletcher T, Garland DJ, Huang W, Jones C, Koeller KJ, Kolodziej SA, Li J, Manning RE, Mahoney MW, Miller RE, Mischke DA, Rath NP, Reinhard EJ, Tollefson MB, Vernier WF, Wagner GM, Rapp SR, Beaudry J, Glenn K, Regina K, Schuh JR, Smith ME, Trivedi JS, Reitz DB.

J Med Chem. 2005 Sep 8;48(18):5853-68.

PMID:
16134951
12.

Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).

Tremont SJ, Lee LF, Huang HC, Keller BT, Banerjee SC, Both SR, Carpenter AJ, Wang CC, Garland DJ, Huang W, Jones C, Koeller KJ, Kolodziej SA, Li J, Manning RE, Mahoney MW, Miller RE, Mischke DA, Rath NP, Fletcher T, Reinhard EJ, Tollefson MB, Vernier WF, Wagner GM, Rapp SR, Beaudry J, Glenn K, Regina K, Schuh JR, Smith ME, Trivedi JS, Reitz DB.

J Med Chem. 2005 Sep 8;48(18):5837-52.

PMID:
16134950
13.

Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model.

Wang K, Tarakji K, Zhou Z, Zhang M, Forudi F, Zhou X, Koki AT, Smith ME, Keller BT, Topol EJ, Lincoff AM, Penn MS.

J Cardiovasc Pharmacol. 2005 Jan;45(1):61-7.

PMID:
15613981
14.

Inhibition of ileal bile acid transport lowers plasma cholesterol levels by inactivating hepatic farnesoid X receptor and stimulating cholesterol 7 alpha-hydroxylase.

Li H, Xu G, Shang Q, Pan L, Shefer S, Batta AK, Bollineni J, Tint GS, Keller BT, Salen G.

Metabolism. 2004 Jul;53(7):927-32.

PMID:
15254889
15.

SC-435, an ileal apical sodium co-dependent bile acid transporter (ASBT) inhibitor lowers plasma cholesterol and reduces atherosclerosis in guinea pigs.

West KL, Zern TL, Butteiger DN, Keller BT, Fernandez ML.

Atherosclerosis. 2003 Dec;171(2):201-10.

PMID:
14644388
16.

A novel class of apical sodium co-dependent bile acid transporter inhibitors: the 1,2-benzothiazepines.

Tollefson MB, Kolodziej SA, Fletcher TR, Vernier WF, Beaudry JA, Keller BT, Reitz DB.

Bioorg Med Chem Lett. 2003 Nov 3;13(21):3727-30.

PMID:
14552767
17.

Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435.

Bhat BG, Rapp SR, Beaudry JA, Napawan N, Butteiger DN, Hall KA, Null CL, Luo Y, Keller BT.

J Lipid Res. 2003 Sep;44(9):1614-21. Epub 2003 Jun 16.

18.

Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB.

Telford DE, Edwards JY, Lipson SM, Sutherland B, Barrett PH, Burnett JR, Krul ES, Keller BT, Huff MW.

J Lipid Res. 2003 May;44(5):943-52. Epub 2003 Feb 1.

19.

Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB.

Huff MW, Telford DE, Edwards JY, Burnett JR, Barrett PH, Rapp SR, Napawan N, Keller BT.

Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1884-91.

PMID:
12426220
21.

A novel class of apical sodium co-dependent bile acid transporter inhibitors: the 2,3-disubstituted-4-phenylquinolines.

Tollefson MB, Vernier WF, Huang HC, Chen FP, Reinhard EJ, Beaudry J, Keller BT, Reitz DB.

Bioorg Med Chem Lett. 2000 Feb 7;10(3):277-9.

PMID:
10698453
22.

Identification and characterization of rhesus macaque interleukin-8.

Minnerly JC, Baganoff MP, Deppeler CL, Keller BT, Rapp SR, Widomski DL, Fretland DJ, Bolanowski MA.

Inflammation. 1995 Jun;19(3):313-31.

PMID:
7628861
23.

SC-54684A: an orally active inhibitor of platelet aggregation.

Nicholson NS, Panzer-Knodle SG, Salyers AK, Taite BB, Szalony JA, Haas NF, King LW, Zablocki JA, Keller BT, Broschat K, et al.

Circulation. 1995 Jan 15;91(2):403-10.

PMID:
7805244
25.

SC-49992--a potent and specific inhibitor of platelet aggregation.

Nicholson NS, Panzer-Knodle SG, King LW, Taite BB, Keller BT, Tjoeng FS, Engleman VW, Giorgio TD, Feigen LP.

Thromb Res. 1994 Jun 1;74(5):523-35.

PMID:
8085253
26.

Selective induction of intercellular adhesion molecule-1 by interferon-gamma in human airway epithelial cells.

Look DC, Rapp SR, Keller BT, Holtzman MJ.

Am J Physiol. 1992 Jul;263(1 Pt 1):L79-87.

PMID:
1353306
27.
28.

Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.

Hasobe M, Mckee JG, Borcherding DR, Keller BT, Borchardt RT.

Mol Pharmacol. 1988 Jun;33(6):713-20.

PMID:
2454388
29.

9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl) derivatives of adenine and 3-deazaadenine: potent inhibitors of bovine liver S-adenosylhomocysteine hydrolase.

Narayanan SR, Keller BT, Borcherding DR, Scholtz SA, Borchardt RT.

J Med Chem. 1988 Mar;31(3):500-3. No abstract available.

PMID:
3346868
30.

S-adenosylmethionine, S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase variations during differentiation of Dictyostelium discoideum.

Guitton MC, Keller BT, Part D, De Gunzburg J, Borchardt RT, Véron M.

Cell Differ. 1988 Feb;22(3):203-10.

PMID:
2833354
31.

Demonstration and structural comparison of receptors for insulin-like growth factor-I and -II (IGF-I and -II) in brain and blood-brain barrier.

Rosenfeld RG, Pham H, Keller BT, Borchardt RT, Pardridge WM.

Biochem Biophys Res Commun. 1987 Nov 30;149(1):159-66.

PMID:
2961336
32.
33.

Adenosine dialdehyde: a potent inhibitor of vaccinia virus multiplication in mouse L929 cells.

Keller BT, Borchardt RT.

Mol Pharmacol. 1987 May;31(5):485-92.

PMID:
3574293
34.

Purification and characterization of some metabolic effects of S-neplanocylmethionine.

Keller BT, Clark RS, Pegg AE, Borchardt RT.

Mol Pharmacol. 1985 Oct;28(4):364-70.

PMID:
3903471
36.
37.

Metabolic conversion of neplanocin A to S-neplanocylmethionine by mouse L 929 cells.

Keller BT, Borchardt RT.

Biochem Biophys Res Commun. 1984 Apr 16;120(1):131-7.

PMID:
6712684
38.
39.

Evidence for more than one mechanism of action of the glucocorticoid hormones.

Keller BT, Landes GM, Kitos PA.

Biochim Biophys Acta. 1982 Aug 6;717(2):228-35.

PMID:
6126221

Supplemental Content

Loading ...
Support Center